Nevertheless, most clinicians consider a PTH level greater than two times normal (>130 pg/mL) to be consistent with persistent post-transplant hyperparathyroidism (PT-HPT) within 12 months post-transplant [6]. The gene discussed is PTH; the disease is hyperparathyroidism.